CaixaBank, S.A.’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.74M Buy
23,258
+8,859
+62% +$2.25M 0.03% 266
2026
Q2
$4.33M Sell
14,399
-127
-0.9% -$38.3K 0.02% 283
2026
Q1
$4.81M Hold
14,526
– – 0.03% 264
2025
Q4
$5.78M Sell
14,526
-216
-1% -$95.6K 0.03% 259
2025
Q3
$6.72M Sell
14,742
-2,065
-12% -$841K 0.03% 263
2025
Q2
$5.48M Buy
16,807
+396
+2% +$110K 0.03% 273
2025
Q1
$4.43M Sell
16,411
-390
-2% -$100K 0.03% 284
2024
Q4
$3.95M Sell
16,801
-1,706
-9% -$449K 0.02% 256
2024
Q3
$5.09M Sell
18,507
-31,288
-63% -$8.15M 0.03% 239
2024
Q2
$12.1M Sell
49,795
-2,134
-4% -$337K 0.07% 150
2024
Q1
$7.76M Buy
51,929
+45,435
+700% +$7.58M 0.05% 188
2023
Q4
$1.24M Sell
6,494
-820
-11% -$140K 0.01% 332
2023
Q3
$1.3M Buy
7,314
+1,224
+20% +$234K 0.01% 327
2023
Q2
$1.15M Hold
6,090
– – 0.01% 336
2023
Q1
$1.22M Buy
6,090
+3,100
+104% +$652K 0.01% 276
2022
Q4
$709K Sell
2,990
-3,082
-51% -$657K 0.01% 303
2022
Q3
$1.21M Sell
6,072
-5,572
-48% -$1.06M 0.01% 275
2022
Q2
$1.69M Hold
11,644
– – 0.02% 265
2022
Q1
$1.9M Sell
11,644
-4,000
-26% -$609K 0.02% 271
2021
Q4
$2.65M Buy
15,644
+2,506
+19% +$466K 0.02% 276
2021
Q3
$2.48M Sell
13,138
-692
-5% -$130K 0.02% 272
2021
Q2
$2.34M Buy
13,830
+852
+7% +$125K 0.02% 268
2021
Q1
$1.83M Buy
12,978
+2,516
+24% +$379K 0.02% 276
2020
Q4
$1.36M Buy
10,462
+10,063
+2,522% +$1.34M 0.01% 279
2020
Q3
$58.1K Buy
399
+148
+59% +$21K ﹤0.01% 341
2020
Q2
$37.2K Buy
+251
New +$33.8K ﹤0.01% 336

Other funds holding ALNY

CaixaBank, S.A.'s ALNY Position: Q3 2026 in Review

CaixaBank, S.A. increased its Alnylam Pharmaceuticals (ALNY) stake by 62% in Q3 2026, buying an estimated $2.25M and bringing the position to 23,258 shares worth $5.74M. The position accounts for 0.03% of the portfolio, ranked #266.

CaixaBank, S.A. first reported a position in ALNY in Q2 2020 and has held it in 26 quarters since. The position peaked at $12.1M in Q2 2024. 726 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • CaixaBank, S.A. held 23,258 shares of Alnylam Pharmaceuticals worth $5.74M as of Q3 2026.
  • CaixaBank, S.A. bought 8,859 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $2.25M.
  • Alnylam Pharmaceuticals made up 0.03% of CaixaBank, S.A.'s portfolio in Q3 2026, its #266 holding.
  • CaixaBank, S.A. first reported a position in Alnylam Pharmaceuticals in Q2 2020 and has held it in 26 quarters since.
  • CaixaBank, S.A.'s Alnylam Pharmaceuticals position peaked at $12.1M in Q2 2024.
  • 726 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on CaixaBank, S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.